| Date | Time | Source | Headline | Symbol | Company |
| 26/03/2015 | 14:12 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 17/02/2015 | 17:10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 20/02/2014 | 22:00 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 04/11/2013 | 19:23 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 30/10/2013 | 10:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 23:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 23:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 22:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 21:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 21:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 21:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 20:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 19:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 19:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 19:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 28/10/2013 | 18:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/10/2013 | 22:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 19:32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 19:32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 19:32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 19:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 19:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 19:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 19:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 19:30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 19:29 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 17:55 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 14:47 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 23/10/2013 | 21:32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 15/10/2013 | 14:23 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |